| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 1 | +165,683 | 25% | $373.73 | +$61,921,024 |
| Sells | 11 | -506,337 | 75% | $402.91 | -$204,009,299 |
| Net | -10 | -340,654 | -51% | -$142,088,275 |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| BAKER BROS. ADVISORS LP | Director | $764,076,617 | +$61,921,024 | +8.8% | 18 Aug 2025 |
| M.D. Rebecca Taub | Director | $604,667,601 | -$48,601,039 | -7.4% | 26 Jan 2026 |
| M.D. Paul A Friedman | Director | $484,919,577 | -$101,802,886 | -17% | 09 Jan 2026 |
| FRED B. CRAVES | Director | $122,538,572 | -$5,082,480 | -4% | 12 Mar 2025 |
| William John Sibold | President and CEO, Director | $73,122,892 | -$8,448,859 | -10% | 26 Jan 2026 |
| Mardi Dier | EVP and CFO | $6,224,171 | -$3,134,009 | -33% | 02 Dec 2025 |
| Alex G. Howarth | Chief Financial Officer | $5,741,877 | 23 Jan 2024 | ||
| Brian J. Lynch | SVP and General Counsel | $5,332,092 | 23 Jan 2024 | ||
| Carole Huntsman | Chief Commercial Officer | $4,511,649 | -$2,130,165 | -32% | 26 Jan 2026 |
| Shannon T. Kelley | General Counsel | $4,252,373 | -$962,825 | -18% | 20 Jan 2026 |
| Remy Sukhija | Chief Commercial Officer | $3,659,044 | 16 Jan 2023 | ||
| David Soergel | Chief Medical Officer | $2,571,336 | 15 May 2025 | ||
| Robert E. Waltermire | Senior VP, Chief Pharma Dev. | $1,995,798 | -$5,235,592 | -72% | 05 Mar 2025 |
| Rita Thakkar | Chief Accounting Officer | $1,396,451 | 15 Jan 2026 | ||
| KENNETH BATE | Director | $1,289,808 | -$18,808,122 | -94% | 05 Nov 2025 |
| James M. Daly | Director | $877,181 | -$5,375,126 | -86% | 20 Jun 2025 |
| Richard S. Levy | Director | $414,742 | -$4,428,198 | -91% | 26 Jan 2026 |
| JACQUALYN A. FOUSE | Director | $366,299 | 20 Jun 2025 | ||
| Daniel J. Brennan | Director | $322,890 | 01 Aug 2025 | ||
| BAY CITY CAPITAL LLC | 10%+ Owner | $307,583 | 03 Dec 2021 | ||
| DAVID MILLIGAN V. | Director | 16 Jun 2022 | |||
| Dr. Raymond Cheong | Director | 15 Jun 2023 | |||
| Keith R. Gollust | Director | 16 Jun 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|